(Total Views: 490)
Posted On: 01/30/2022 5:35:06 PM
Post# of 22465
Re: Puravida19 #21323
Quote:
1. gaining initial Vac-check and
anticounterfeiting clients would be huge news by itself,
Absolutely, ,it stand to reason IF QMC is part of the Pasaca Capital/ Innova Medical Group family Innova would look to a member of their family to protect their products and recommend a member of their family to their partners Sinopharm (especially vac-check here) and Xiamen Biotime for their products protection.
" Pasaca Capital Inc, the private equity firm that owns one of the worlds largest COVID-19 test providers, Innova Medical Group, Inc., and Sinopharm's China National Biotech Group (CNBG), one of the largest vaccine producers in the world, announced yesterday the establishment of a global joint venture - Sino-Innovax Biotech Pte Ltd. .
The joint venture will initially focus on the manufacturing and global distribution of Sinopharm's virus inactivated COVID-19 vaccines and will include other vaccines currently produced or in development by CNBG".
Quote:
2. if one pharma signs up then others would follow,
I am saying that having two major players in the Chinese pharmaceutical space as partners of the controlling owner (Sinopharm and Xiamen Biotime) will open many doors for QMC.
Quote:
3. good possibility of product diversification using QD as differentiator.
Yes based on the August 25 2021 update " We are currently developing 1) LFTs (lateral flow test kits) for TBI (traumatic brain injury, aka concussions), 2) a multiplex test that detects Covid-19, Flu and RSV (Respiratory Syncytial Virus), and 3) a vaccine validator to thwart counterfeit vaccines and validate vaccine efficacy. This test kit technology uses a unique quantum dot as a signal amplifier and can give a visual test result indication using a low-cost UV light source or using our POCT reader to interface with a P.C. or a smartphone. "
Quote:
4. if Samsung is not using QMC QD, it's possible others, perhaps Taiwanese display manufacturers might, to produce a competing product. A long shot, but you know, it's not over till it's over.
It's possible.
(0)
(0)
